|
|
| | Autoinducing Peptide I Basic information |
| Product Name: | Autoinducing Peptide I | | Synonyms: | Autoinducing Peptide I;2-[(3S,6S,9S,12S,15R)-15-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxybutanoyl]amino]-9-benzyl-6-[(2S)-butan-2-yl]-3-(2-methylsulfanylethyl)-2,5,8,11,14-pentaoxo-1-thia-4,7,10,13-tetrazacyclohexadec-12-yl]acetic acid;L-Methionine, L-tyrosyl-L-seryl-L-threonyl-L-cysteinyl-L-α-aspartyl-L-phenylalanyl-L-isoleucyl-, (8→4)-thiolactone;AIP-I (0.5 mg vial) | | CAS: | 200010-29-3 | | MF: | C43H60N8O13S2 | | MW: | 961.12 | | EINECS: | | | Product Categories: | | | Mol File: | 200010-29-3.mol |  |
| | Autoinducing Peptide I Chemical Properties |
| Boiling point | 1434.3±65.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | pka | 4.02±0.10(Predicted) | | form | Solid | | color | White to off-white | | Sequence | Tyr-Ser-Thr-Cys-Asp-Phe-Ile-Met (Thioester bridge:Cys4-Met8) |
| | Autoinducing Peptide I Usage And Synthesis |
| Uses | Autoinducing Peptide I is a cyclic octapeptide secreted by Staphylococcus aureus and can be used in vaccine research[1]. | | References | [1] Daly SM, et al. VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation. Sci Rep. 2017 Apr 4;7(1):637. DOI:10.1038/s41598-017-00753-0 |
| | Autoinducing Peptide I Preparation Products And Raw materials |
|